BarbeloPodcast Library
DocSnipes
DocSnipes·September 25, 2020

Medication-Assisted Therapies: An Integrated Approach to Addiction Recovery

Watch on YouTube

Summary

Medication-Assisted Therapies (MAT) offer crucial support for individuals struggling with addiction, particularly during the challenging early recovery phase. The core purpose of MAT is to help stabilize neurotransmitter imbalances, reduce intense cravings, and alleviate anxiety and depressive symptoms that often drive substance use. This approach aims to enhance a client's self-efficacy and sense of control, enabling them to engage more effectively in their recovery journey. While not a standalone solution, MAT serves as a vital bridge, making the transition to sobriety more manageable for those who have previously struggled with abstinence. The podcast emphasizes that MAT is typically a time-limited intervention, often lasting one to two years, designed to support individuals while they develop new coping skills and a stable recovery lifestyle.

A key distinction highlighted is that MAT is not a substitute for counseling but rather a complementary component of a comprehensive treatment plan. It is most effective when integrated with psychosocial support, addressing the emotional, cognitive, physical, social, occupational, and environmental factors contributing to addiction. The discussion underscores that co-occurring mental health disorders are the norm, not the exception, in addiction recovery, necessitating a holistic approach that tackles underlying issues like depression, anxiety, grief, and guilt. Understanding the function of addictive behaviors—whether self-medicating pain, mood disorders, or seeking respite from distress—is paramount to developing alternative, more rewarding coping strategies. The podcast acknowledges that while immediate gratification from drugs may be intense, MAT helps individuals focus on the long-term fulfillment of sustained recovery.

Practical considerations for implementing MAT include cost, availability, potential side effects, and barriers such as workplace drug testing or incarceration. The speaker details specific pharmacotherapies for nicotine (patches, gums, bupropion, varenicline), alcohol (Antabuse, Campral, naltrexone), and opioids (methadone, buprenorphine/Suboxone, Vivitrol). It's crucial to assess client motivation, as MAT is not a "magic pill" but requires active engagement in the recovery process. Contraindications, such as combining certain MATs with alcohol or benzodiazepines, are also stressed due to potential lethality. The podcast also touches upon the lack of pharmacotherapies for stimulants and hallucinogens, though some medications like bupropion are being studied for stimulant use.

Broader implications include addressing the pervasive stigmatization of MAT, which is often mistakenly viewed as merely substituting one drug for another. The podcast strongly advocates for MAT as an evidence-based treatment, citing research that demonstrates significantly better outcomes for individuals maintained on it for at least a year. It also notes the evolving acceptance of MAT within 12-step communities and the critical need for counselors to educate themselves beyond anecdotal information. Ultimately, MAT represents a harm reduction strategy that, when properly integrated into a person-centered, flexible treatment plan, can significantly improve recovery outcomes, reduce disease transmission, and decrease crime rates, fostering long-term stability and well-being.

Key Quotes

"my goal is not to you know advocate one way or another because treatment is appropriate uh different treatments are appropriate for different clients but i think it is important that we're aware of it."
"medication assisted therapy for the majority of people like 98 point something percent the majority of people on medication assisted therapy are only on it for a period of a year to two years maybe a little bit more."
"we always want to ask ourselves and maybe the client why is it that you chose this drug what does it do for you because different drugs do different things because they attach to different neurotransmitter receptors."
"the goal is not to substitute one drug for another to create give them a quote legal high the goal is to take the edge off so or put things in place so using is unpleasant."
"it is not a substitute for counseling we i know i've said it like three times already and this is so important because too often i see people going places and getting medication-assisted therapy but not partaking in counseling."
"remember that co-occurring disorders are the expectation not the exception most people who are in addiction recovery or a significant proportion are going to have co-occurring issues."
"learned behaviors cannot be unlearned that's why relapse is such a problem sometimes because people have learned that hey you know when things get really bad if i use this drug if i do this it numbs the pain for a minute it gives me some respite."
"the dogma out there is that people are replacing one drug for another and you know i want to think about it for a second yeah you've got people that are taking illicit drugs or are having to you know get drugs from somewhere buy them off the street mix over-the-counter medications with prescriptions whatever they're doing that is very uncontrolled and can be very dangerous and they can get high."
"evidence-based treatment is you know medication-assisted therapy is evidence-based treatment they've done the studies they've shown that the outcomes are much better."

Concepts

Themes

  • Integrated Addiction Treatment
  • Neurobiological Basis of Addiction and Recovery
  • Harm Reduction Philosophy
  • Addressing Stigma in Healthcare
  • Holistic Patient-Centered Care
  • Relapse Prevention and Skill Development
  • Importance of Psychosocial Support
  • Pharmacological Interventions for Substance Use Disorders

Related to:

Health Insights

Clinical Recommendations

  • Integrate MAT with psychosocial counseling
  • Address co-occurring mental health issues
  • Develop individualized relapse prevention plans
  • Educate clients on MAT purpose and risks
  • Consider biopsychosocial factors in treatment planning

Therapeutic Techniques

  • Counseling
  • Relapse prevention planning
  • Sleep hygiene education
  • Nutrition education
  • Routine maintenance
  • Developing alternative rewarding behaviors

Mechanisms Explained

  • Partial opioid agonism (buprenorphine, varenicline)
  • Mu opioid agonism (methadone)
  • Norepinephrine and dopamine reuptake inhibition (bupropion)
  • Acetyl-dehyde dehydrogenase blockade (Antabuse)
  • Serotonin receptor 5 HT2A action (psychedelics)
  • Glutamate reduction (dissociatives)
  • Acetylcholine reduction (deliriants)

Medications Discussed

  • Methadone
  • Suboxone (buprenorphine)
  • Vivitrol (naltrexone injection)
  • Bupropion (Wellbutrin/Zyban)
  • Varenicline (Chantix)
  • Antabuse (Disulfiram)
  • Campral (Acamprosate)
  • Naltrexone (oral)
  • Ketamine
  • Dextromethorphan
  • Benadryl
  • Dramamine

Target Substances

  • Opioids
  • Alcohol
  • Nicotine
  • Stimulants (methamphetamine, cocaine, Adderall)
  • Hallucinogens (psychedelics)
  • Dissociatives
  • Deliriants
  • Inhalants
  • Marijuana

Similar Episodes